Acute heart failure: reality and recommendations

September 05, 2005

The number of hospitalizations for heart failure is about the same as for acute myocardial infarction. Our knowledge over acute heart failure patients treated at hospitals for heart failure is based on surveys. In Europe the information is still scarce but emerging especially through the European Society of Cardiology (ESC) Euroheart survey program.

In the Euroheart Heart Failure I survey performed in 2000, which collected information from 10701 patients treated by heart failure medication particularly diuretics on emergency basis and onward found out that 47% of the patients were females and 51% of them were over 75 years old. In male subjects, 30% were older than 75 years. As stated, the number of hospitalizations for heart failure is about the same as for acute myocardial infarction and moreover 30% of acute coronary syndrome patients have mild or severe heart failure.

In Euroheart II, which is a European survey on characteristics of acute heart failure in Europe, 40% of unselected patient population are females. In female acute heart failure patients the prevalence of acute new onset heart failure is 44% and higher than in male subjects. The female subjects are older with mean age of 73 years compared to 68 years in male subjects.

During the last decade, heart failure has received increased attention due to the cost of care for the society. The hospitalizations are long from 3 - 21 days depending on the severity, mean 9 days, including at least one day in intensive care or corresponding specialty care units with higher cost. The mean cost can be an estimated 3000€ per hospitalization without special investigations.

Out of the acute heart failure patients 60% have known heart failure and 40% are patients with acute cardiac emergency causing heart failure. Thirty-five percent of patients undergo cardiac catheterization and interventions are frequent, especially in patients who present with acute and new heart failure as many of these are caused by acute coronary syndrome.

Mortality is high, in hospital 7% and during three-month follow up 10%. The mortality in cardiogenic shock patients is 70 - 80%.

The ESC has recently in January 2005 issued European guidelines on acute heart failure, which institutes the definition and classification of acute heart failure and delineates our current evidence and expert opinion on acute heart failure therapy. The ongoing Euroheart survey elucidates the causes and treatment of acute heart failure and in its ongoing follow-up the therapy after hospitalization as well as prognosis.

There are several complicating factors in the course of our patients. Seventeen percent of females have anemia, partly related to age. Thirty-one percent have atrial arrythmias, especially atrial fibrillation. Some of the patients have ventricular tachycardias or life threatening arrythmias. In male subjects history of smoking is frequent and they often have more chronic lung diseases. Eight percent of patients have pneumonia at entry. Renal insufficiency, usually mild is frequent, with 16%. Diabetes is complicating the course in 34% of females and 30% of male subjects. New research is warranted and needed and in the future our treatment practises should be evaluated with proper research.

Heart failure patients are "a country" in Europe, there are so many. Acute heart failure hospitalizations are as frequent as myocardial infarction and moreover it is complicating many of our coronary patients. ESC guidelines will standardize the care of acute heart failure patients, but fresh research and development of medical care is welcome to improve the prognosis and to lower the cost.
-end-
References:
J. G. Cleland, K. Swedberg, F. Follath, M. Komajda, A. Cohen-Solal, J. C. Aguilar, R. Dietz, A. Gavazzi, R. Hobbs, J. Korewicki, H. C. Madeira, V. S. Moiseyev, I. Preda, W. H. van Gilst, J. Widimsky, N. Freemantle, J. Eastaugh and J. Mason, The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis, Eur Heart J 24(2003), 442-463.

European Society of Cardiology

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.